South Korea Pharmaceuticals & Healthcare Report Q1 2014 - New Study Released
South Korea continues to invest in pharmaceutical research and development (R&D). In one of the latest developments in this area, the South Korea Health Ministry announced in July 2013 that it will spend a total of KRW10trn (US$8.9bn) on projects to develop 20 new drugs over the next five years, in partnership with private domestic drugmakers. The government will also establish a KRW500bn (US $448mn) fund to help local pharmaceutical firms expand their presence globally. Additionally, despite the downgrade in...
View full press release